TransMedics Heart Transplant Tool Lands FDA Panel Date After 6-Month Delay

The US agency’s circulatory system devices panel will take up the company’s heart transplant tool in an October virtual session.

FDA Advisory Committee Feature image

More from Regulation

More from Policy & Regulation